Article | March 26, 2026

Part 1: Why AI In Life Sciences Must Be Grounded In Validated Execution

Source: Emerson

By Nikki Bishop, Emerson

The standard digital playbook says to unify the data, add AI, and let enterprise insight follow. In regulated life sciences production, that sequence runs into a hard constraint: the batch record, executed workflow, material genealogy, and release decision are the system of record, and they carry legal weight. Analytics datasets that drift from validated execution create parallel versions of reality, and batch behavior such as phase-dependent analysis windows defeats tools built for fixed timestamps. This first installment of a two-part series is for manufacturing, IT, and quality leaders deciding where AI sits in the stack. Explore the argument for keeping insight inseparable from execution.

Access The Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.

Subscribe to Cell & Gene X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Cell & Gene